Toggle navigation
Home
Search
Services
Blog
Contact
About
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexandria A.
Osi Pharmaceuticals, Inc., Uniondale, NY, United States
Search 8 grants from Alexandria Stewart
Search grants from Osi Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of Sirtuins in mediating telomere and p53-dependent aging and disease
Therapeutic potential for AAV/micro-dystrophin transfer to cardiopulmonary tissue
Molecular Genetic Alterations of Endometrial Carcinoma
Consequences of Thc Induced Structural Changes in CNS
Significance of Nitrosourea Formation From Creatinine
Recently added grants:
CD166 Regulates Human and Murine Hematopoietic Stem Cell Function and the Hematopoietic Niche
PRedOctoral phd and md research training in TEams (PROmoTE)
Mechanisms regulating neurotensin secretion and function
Improving HSC transplantation by defining novel regulators of engraftment
Mechanisms regulating the aging of HSC niches
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44DK049882-03
Application #
2796589
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (14))
Program Officer
Harmon, Joan T
Project Start
1995-06-15
Project End
2000-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Osi Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Uniondale
State
NY
Country
United States
Zip Code
11553
Related projects
NIH 1999
R44 DK
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexandria A. / Osi Pharmaceuticals, Inc.
NIH 1997
R44 DK
Hexokinase II Transcription as Antidiabetic Drugs
Stewart, Alexander A. / Osi Pharmaceuticals, Inc.
Comments
Be the first to comment on Alexandria Stewart's grant